Medical News

RSS

Thomas Jefferson University Hospital commences live donor liver transplant program

The Division of Transplantation in the Department of Surgery at Thomas Jefferson University Hospital (TJUH) has started a live donor liver transplant program. Live donor liver transplantation (LDLT) is a procedure in which a living person donates a portion of his or her liver to another person. Combined, the two operations typically take about 12 hours. Since the program began in summer 2010, three patients and their donors have successfully undergone the procedure.

4 Oct 2010

JASH journal added to MEDLINE collection

Elsevier announces that the Journal of the American Society of Hypertension (JASH) has been selected for inclusion in MEDLINE. MEDLINE is the premier bibliographic database of the U.S. National Library of Medicine (NLM), containing over 15 million journal article citations, with a concentration on biomedicine.

4 Oct 2010

Cost-effective ways for early detection of 'lazy eye'

Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. In amblyopia the person's stronger eye is favored and his/her weaker eye gradually loses visual power as a result. When the condition is detected and treated before age 7, more than 75 percent of children achieve 20/30 vision or better, the Amblyopia Treatment Study reports.

4 Oct 2010

Study may provide informed use of growth hormone in muscle development, muscle loss

Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.

4 Oct 2010

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

4 Oct 2010

IRSF awards $1.5M in research grants for Rett syndrome treatment

The International Rett Syndrome Foundation (IRSF) announced today that it will award an additional $1.5M in research grants, bringing the 2010 total to $2.15 million for innovative basic and translational research that moves treatments for Rett syndrome a step closer to the clinic.

4 Oct 2010

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.

4 Oct 2010

Saturated fat intake has limited impact on CVD risk: Research

For the past three decades, saturated fat has been considered a major culprit of cardiovascular disease (CVD) and as a result dietary advice persists in recommending reduced consumption of this macronutrient. However, new evidence shows that saturated fat intake has only a very limited impact on CVD risk causing many to rethink the "saturated fat is bad" paradigm.

4 Oct 2010

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Senior Vice President, Dean Tozer and Vice President of Government Affairs and Health Economics, Therésa Dixon will speak on behalf of the Company at the 2010 World Stem Cell Summit, sharing their more than 30 years of combined industry experience with attendees.

4 Oct 2010

Noninvasive embryo assessment technology may improve success rates for in vitro fertilization procedures

Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that it acquired an exclusive license from Stanford University to develop a set of products that may allow medical practitioners in the field of assisted reproduction to significantly improve the effectiveness of in vitro fertilization (IVF) procedures.

4 Oct 2010

Rate of chemotherapy administration for NSCLC more than twice that reported by SEER

For the first time to date, research published in the October edition of the Journal of Thoracic Oncology (JTO) sought to determine the use of chemotherapy in a contemporary, diverse non-small cell lung cancer (NSCLC) population encompassing all patient ages. Prior population-based studies have shown that only 20 to 30 percent of advanced lung cancer patients receive chemotherapy treatment.

4 Oct 2010

New SymPath kit measures DBH activity of Sympathetic Nervous System

Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.

4 Oct 2010

NIH to award $64M under Transformative Research Projects program

The National Institutes of Health will award up to $64 million over five years to encourage exploration of exceptionally innovative and original research ideas that have the potential for extraordinary impact.

4 Oct 2010

Mandatory ECG screening for athletes

Should athletes have to undergo mandatory electrocardiographic screening (also known as ECG or heart trace) before competing? Doctors debate the issue in this week's BMJ.

4 Oct 2010

Study shows hypomethylation increases through progression of multiple myeloma

DNA methylation, a modification of DNA linked to gene regulation — is altered with increasing severity in a blood cancer called multiple myeloma, according to a study by Mayo Clinic and the Translational Genomics Research Institute (TGen).

4 Oct 2010

OHSU CROET issues public alert on Brazilian Blowout hair straightening product

Oregon Health & Science University's Center for Research on Occupational and Environmental Toxicology (CROET) is responding to concerns raised by Portland-area hair salons about a product used for hair straightening. CROET has issued two public alerts describing its findings on the possible negative health impacts of this product.

4 Oct 2010

Neupro improves quality of life in Parkinson's disease patients

People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms.

4 Oct 2010

Californian Hispanics at lower risk of developing melanoma, but develop the disease at younger age

Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.

4 Oct 2010

UofL School of Nursing awarded $792,000 grant to develop nursing informatics education

The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.

4 Oct 2010

Merck to appeal Massachusetts federal court jury verdict

Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.

4 Oct 2010

Medical News

Thomas Jefferson University Hospital commences live donor liver transplant program

JASH journal added to MEDLINE collection

Cost-effective ways for early detection of 'lazy eye'

Study may provide informed use of growth hormone in muscle development, muscle loss

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

IRSF awards $1.5M in research grants for Rett syndrome treatment

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

Saturated fat intake has limited impact on CVD risk: Research

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

Noninvasive embryo assessment technology may improve success rates for in vitro fertilization procedures

Rate of chemotherapy administration for NSCLC more than twice that reported by SEER

New SymPath kit measures DBH activity of Sympathetic Nervous System

NIH to award $64M under Transformative Research Projects program

Mandatory ECG screening for athletes

Study shows hypomethylation increases through progression of multiple myeloma

OHSU CROET issues public alert on Brazilian Blowout hair straightening product

Neupro improves quality of life in Parkinson's disease patients

Californian Hispanics at lower risk of developing melanoma, but develop the disease at younger age

UofL School of Nursing awarded $792,000 grant to develop nursing informatics education

Merck to appeal Massachusetts federal court jury verdict

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News